Prednisolone +/- Addition of Anti-CD20 Antibody, Rituximab, in Patients With Immune Hemolytic Anemia

Clinical trial NCT01134432 · COMPLETED

Trial details

NCT number: NCT01134432
Sponsor: Copenhagen University Hospital at Herlev
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Anemia, Hemolytic, Autoimmune

Start date: 2005-03-01
Primary completion: 2012-07-01
Enrollment: 65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.